Reduction of heart failure guideline‐directed medication during hospitalization: prevalence, risk factors, and outcomes
Abstract Aims Optimal management of heart failure with reduced ejection fraction (HFrEF) includes titration of guideline‐directed medical therapy (GDMT) to the highest tolerated dose within the licensed range. During hospitalization, GDMT doses are often significantly altered, although it is unknown...
Guardat en:
| Autors principals: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2022-10-01
|
| Col·lecció: | ESC Heart Failure |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/ehf2.14051 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
